NB

Nordic Biotech

North America, South Carolina, United States, Denmark

Description

Nordic Biotech Advisors was founded in 2001, and currently advises Nordic Biotech K/S and Nordic Biotech II K/S.

Investor Profile

Nordic Biotech has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (75%)
  • Series B (25%)

Country Focus

  • Denmark (75%)
  • United Kingdom (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Medical Device
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nordic Biotech frequently co-invest with?

Vaekstfonden
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
SEB Venture Capital
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
SLS Venture
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1

What are some of recent deals done by Nordic Biotech?

Gastrotech Pharma

Copenhagen, Hovedstaden, Denmark

Gastrotech Pharma A/S is a newly founded company focusing on medical application of gastrointestinal hormones.

Health CareMedical DevicePharmaceutical
Series ANov 13, 2003
Nuevolution

Copenhagen, Hovedstaden, Denmark

Nuevolution, a small molecule lead discovery company, conducts drug discovery in partner-funded programs and collaborative projects.

BiotechnologyHealth CareMedical
Series BOct 10, 2003
Amount Raised: $15,000,000
Biotica Technology

Cambridge, Cambridgeshire, United Kingdom

Biotica Technology engages in the discovery and development of drugs for the treatment of cancer and inflammatory diseases.

BiotechnologyTherapeutics
Series AJan 10, 2003
Amount Raised: $5,000,000
Nuevolution

Copenhagen, Hovedstaden, Denmark

Nuevolution, a small molecule lead discovery company, conducts drug discovery in partner-funded programs and collaborative projects.

BiotechnologyHealth CareMedical
Series ADec 3, 2001
Amount Raised: $4,789,257